Registration for the 2022 CMA Training Course is now open!

The 2022 Certified Medication Assisted Treatment Advocate (CMA) Course will be held as a Pre-Conference Session of the 2022 AATOD Conference on:Sunday, October 30, 2022
9:00am – 5:00pm
Hilton Baltimore Inner Harbor
401 W. Pratt Street
Baltimore, MD 21201We encourage all supporters of MAT, patient and non-patient, to become Certified MAT Advocates so that all energies directed toward the advancement of MAT produce positive results.In 1988 when NAMA Recovery first started, methadone advocacy was a few committed individuals who all knew one another. When on those rare occasions that a new advocate became active, she or he was mentored by a more experienced advocate.A few mistakes were made but the same mistake was seldom made twice. The result of a small tight knit group closely collaborating.MAT Advocacy is no longer a few committed individuals. Hundreds of people with various degrees of skill and knowledge now call themselves MAT Advocates and hundreds more are interested in becoming a Certified MAT Advocate (CMA) if the training is made available.NAMA Recovery is taking the lead to ensure that there is a standard for MAT advocates and to maintain the level of professionalism that is expected from a NAMA Recovery advocate. It is also important that new MAT advocates have the same opportunities of those that came before them. NAMA Recovery’s wealth resides with our dedicated advocates who are willing to share their experience with others who also want to make a difference.Therefore, this training course has the potential to make significant changes in MAT by creating a powerful national group of patients and professionals who see themselves as a community that is working towards a common goal. For far too long MAT has been misunderstood and disparaged; It is past time for MAT to be recognized as the “Gold Standard” treatment for opioid use disorder that it is.You become a certified patient advocate by taking the Patient Advocate Training Course, agreeing to abide by the Code of Ethics, and to support the goals of advocacy. Each individual who applies is reviewed by the certification committee. If approved, you will receive your certification in mail.REGISTER NOW!To register for the 2022 Certified MAT Training Course, you may CLICK HERE or simply scan the QR code below:© 2022 National Alliance for Medication Assisted Recovery, Inc.

Similar Posts

  • Stop Methadone Ignorance

    Admin 05/22/2021

    STOP METHADONE IGNORANCE It is not uncommon for individuals with a long history of illicit opiate use to remain in methadone treatment as a long term patient. Many often say that without methadone treatment they would probably be dead. Other forms of treatment were not effective and they had come to believe that they would…

  • TRIPS Update

    Admin 08/29/2021

    TRIPS No Longer Operating This past Spring TRIPS the project that assists methadone patients to find an alternative site while traveling was closed. It happened very quickly and as you would expect created problems immediately. NAMA began receiving calls as early as March from patients trying to locate a program in the area that they…

  • Risk Factors for HCV

    Admin 03/22/2023

    HCV Info Fact 24 August 2003 The risk factors for Hepatitis C Virus infection are: Intravenous drug use- Current or remote intravenous drug use accounts for 50% of new cases of HVC; 50% to 60% infected with HCV within 3 months of initiation of injection behavior Intranasal cocaine- Risk factor suggested by epidemiologic evidence Tattooing…

  • NAMA Needs Volunteers!

    Admin 02/05/2022

    Contact the Executive Director NAMA Recovery needs help with two major things: 1. Website, 2. Funding. Programmers to help with the website. Funding Membership Drives or just asking your program if you can hang up some NAMA Recovery flyers that can bring in new members and of course spread the word about what we do….

  • Orlaam(LAAM) Alert

    Admin 06/17/2021

    FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

  • Publication Index

    Admin 02/09/2022

    Journal Articles Anderson, J. Methadone, history, pharmacology, outcomes, clinical issues and future trends. Advance 2002 April: 42-48. (PDF Format) Coates, E.A.; Brennan, D.; Logan, R.M.; Goss, A.N.; Scopacasa, B.; Spencer, A.J.; Gorkic, E. Hepatitis c and associated health problems. Australian Dental Journal 2000 45(2): 108-114. (PDF Format) D’Aunno, T.; Pollack, H.A. Changes in Methadone Treatment…